Thermo Fisher Scientific Files Additional Proxy Materials
Ticker: TMO · Form: DEFA14A · Filed: 2026-04-07T08:16:00-04:00
Sentiment: neutral
Topics: proxy-filing, regulatory, corporate-governance
TL;DR
Thermo Fisher dropped more proxy docs, check 'em before the shareholder meeting.
AI Summary
Thermo Fisher Scientific Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 7, 2026. This filing includes materials related to the company's annual meeting, likely concerning executive compensation, board nominations, or shareholder proposals. The filing is a supplement to their initial proxy statement and provides additional information for shareholders.
Why It Matters
This filing provides shareholders with supplementary information crucial for making informed decisions at the upcoming annual meeting, particularly regarding corporate governance and executive compensation.
Risk Assessment
Risk Level: low — This is a routine regulatory filing for a public company and does not indicate any immediate financial or operational risks.
Key Players & Entities
- THERMO FISHER SCIENTIFIC INC. (company) — Filer
- 0000097745 (company) — CIK Number
- 0000097745-26-000082 (filing_id) — SEC Accession Number
- 2026-04-07 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for Thermo Fisher Scientific?
This is a Definitive Additional Materials proxy soliciting material filed under Rule 14(a)(12).
When was this DEFA14A filing accepted by the SEC?
The filing was accepted on April 7, 2026.
What is the CIK number for Thermo Fisher Scientific?
The CIK number for Thermo Fisher Scientific is 0000097745.
What is the primary business classification (SIC code) listed for Thermo Fisher Scientific?
The SIC code listed is 3829 for Measuring & Controlling Devices, NEC.
Where is Thermo Fisher Scientific's principal executive office located?
The principal executive office is located at 168 THIRD AVENUE WALTHAM MA 02451.
Filing Stats: 130 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2026-04-07 08:16:00
Filing Documents
- a2026proxynotice.htm (DEFA14A) — 13KB
- a2026proxy-nacardfinal_pag.jpg (GRAPHIC) — 500KB
- a2026proxy-nacardfinal_paga.jpg (GRAPHIC) — 439KB
- image1.jpg (GRAPHIC) — 80KB
- 0000097745-26-000082.txt ( ) — 1418KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Rule 14a-101) SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.__ ) Filed by the Registrant Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under Section 240.14a-12 Thermo Fisher Scientific Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.